Effect of the Million Hearts Cardiovascular Disease Risk Reduction Model on Initiating and Intensifying Medications: A Prespecified Secondary Analysis of a Randomized Clinical Trial

IMPORTANCE: The Million Hearts Cardiovascular Disease (CVD) Risk Reduction Model pays provider organizations for measuring and reducing Medicare patients’ cardiovascular risk. OBJECTIVE: To assess whether the model increases the initiation or intensification of antihypertensive medications or statin...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:JAMA Cardiol
Main Authors: Peterson, G. Greg, Pu, Jia, Magid, David J., Barterian, Linda, Kranker, Keith, Barna, Michael, Conwell, Leslie, Rose, Adam, Blue, Laura, Markovitz, Amanda, McCall, Nancy, Markovich, Patricia
Format: Artigo
Jezik:Inglês
Izdano: American Medical Association 2021
Teme:
Original Investigation
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8173467/
https://ncbi.nlm.nih.gov/pubmed/34076665
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2021.1565
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki